R&D Systems™ Recombinant Human Bcl-w (minus C-Terminus) Protein

Description

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Inhibition Activity

The Recombinant Human Bcl-w (minus C-Terminus) Protein is derived from E. coli. The Recombinant Human Bcl-w (minus C-Terminus) Protein has been validated for the following applications: Inhibition Activity.

Specifications

• Formulation: Supplied as a 0.2μm filtered solution in HEPES, NaCl and Glycerol.
• Gene ID (Entrez): 599
• Molecular Weight (g/mol): 19.5 kDa
• Name: Bcl-w Minus C-Terminus
• Quantity: 50 μg
• Source: E. coli-derived human Bcl-w protein Ala2-Thr172,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening.
• Structural Form: Monomer and disulfide-linked homodimer
• Endotoxin Concentration: <0.01 EU per 1μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.